Insulin therapy helps control blood sugar levels in diabetes. What type of insulin you take, how often you take it, and how it’s administered are all part of your individualized treatment plan. For ...
Daily Express US on MSN
Diabetes breakthrough as century-old medicine 'helps manage type 1 diabetes'
A clinical trial found that metformin, a drug typically used for type 2 diabetes, reduced insulin requirements by around 12% ...
The FDA is on a roll. Fresh off handing down an approval to Medtronic’s latest insulin pump, the agency has doled out a nod for yet another diabetes device, this time to Insulet. In contrast to ...
A Garvan-led clinical trial has found that using a common and inexpensive type 2 diabetes drug reduces insulin needs in type ...
Scientists say the discovery opens doors for improved management of the condition. The post 100-year-old medication could ...
(CNN) -- A weekly dose of semaglutide, the key ingredient in blockbuster medications Ozempic and Wegovy, helped seven out of 10 patients newly diagnosed with type 1 diabetes stop taking insulin after ...
Embecta has secured an FDA clearance for its first wearable insulin delivery system, with a patch pump designed for people with either Type 1 or Type 2 diabetes. The fully disposable device includes a ...
The Centers for Disease Control and Prevention (CDC) state that in the last 20 years, the number of adults diagnosed with diabetes has more than doubled. The primary treatment for type 1 diabetes is ...
Type 1 diabetes is an autoimmune disease (typically arising in younger people) that occurs when your immune system attacks ...
In the early 1950s, British physician Philip Hugh-Jones was flummoxed by 13 patients who showed up at the diabetes clinic he ran near Kingston, Jamaica. At the time, researchers broadly recognized two ...
A weekly dose of semaglutide, the key ingredient in blockbuster medications Ozempic and Wegovy, helped seven out of 10 patients newly diagnosed with type 1 diabetes stop taking insulin after three to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results